Systemic therapy of necrobiotic xanthogranuloma: a systematic review

15Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Even though a plethora of systemic therapies have been proposed for necrobiotic xanthogranuloma (NXG), there is no systematic review on this topic in literature. Objective: To review all existing literature on the systemic therapy of NXG in order to identify the most effective therapies. Methods: All reported papers in the literature were screened for systemic treatments of NXG. Papers without proper description of the therapies, papers describing topical therapy, and articles without assessment of effectiveness were excluded. Subsequently, we analyzed 79 papers and a total of 175 cases. Results: The most effective treatments for NXG are intravenous immunoglobulins (IVIG), corticosteroids, and combination therapies including corticosteroids. Conclusions: Corticosteroids and IVIG should therefore be considered first-line treatments in patients with NXG.

Cite

CITATION STYLE

APA

Steinhelfer, L., Kühnel, T., Jägle, H., Mayer, S., Karrer, S., Haubner, F., & Schreml, S. (2022, December 1). Systemic therapy of necrobiotic xanthogranuloma: a systematic review. Orphanet Journal of Rare Diseases. BioMed Central Ltd. https://doi.org/10.1186/s13023-022-02291-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free